Total Payments
$31,217
2024 Payments
$1,693
Companies
14
Transactions
66
Payment Breakdown by Category
Other$24,114 (77.2%)
Travel$2,935 (9.4%)
Consulting$2,800 (9.0%)
Food & Beverage$1,368 (4.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,114 | 15 | 77.2% |
| Travel and Lodging | $2,935 | 9 | 9.4% |
| Consulting Fee | $2,800 | 3 | 9.0% |
| Food and Beverage | $1,368 | 39 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22,593 | 25 | $0 (2020) |
| Global Blood Therapeutics, Inc. | $5,285 | 9 | $0 (2021) |
| PFIZER INC. | $2,906 | 5 | $0 (2024) |
| CSL Behring | $120.98 | 6 | $0 (2020) |
| Shire North American Group Inc | $53.39 | 4 | $0 (2019) |
| Novo Nordisk Inc | $48.45 | 3 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $46.08 | 3 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $43.70 | 2 | $0 (2019) |
| Grifols USA, LLC | $39.91 | 3 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $22.37 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,693 | 3 | PFIZER INC. ($1,693) |
| 2023 | $1,200 | 1 | PFIZER INC. ($1,200) |
| 2021 | $3,525 | 6 | Global Blood Therapeutics, Inc. ($3,525) |
| 2020 | $8,845 | 10 | Novartis Pharmaceuticals Corporation ($7,061) |
| 2019 | $6,388 | 20 | Novartis Pharmaceuticals Corporation ($6,228) |
| 2018 | $126.62 | 9 | Novo Nordisk Inc ($30.96) |
| 2017 | $9,439 | 17 | Novartis Pharmaceuticals Corporation ($9,291) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 04/04/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $93.21 | General |
| Category: HEMATOLOGY | ||||||
| 04/01/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 10/23/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 09/01/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $705.00 | General |
| 05/13/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 04/14/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $235.00 | General |
| 03/23/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $470.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 03/12/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $470.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 02/17/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $705.00 | General |
| 11/12/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $160.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/25/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $320.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/06/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,280.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 02/07/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: HEMATOLOGY | ||||||
| 02/05/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,050.00 | General |
| Category: HEMATOLOGY | ||||||
| 02/05/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $124.01 | General |
| Category: HEMATOLOGY | ||||||
| 02/05/2020 | CSL Behring | — | Food and Beverage | In-kind items and services | $24.12 | General |
| 01/29/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,660.00 | General |
| Category: HEMATOLOGY | ||||||
| 01/29/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Travel and Lodging | Cash or cash equivalent | $113.28 | General |
| Category: HEMATOLOGY | ||||||
| 01/29/2020 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $94.84 | General |
| Category: HEMATOLOGY | ||||||
| 12/04/2019 | Bayer HealthCare Pharmaceuticals Inc. | Jivi (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Hematology | ||||||
| 10/29/2019 | Novartis Pharmaceuticals Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,050.00 | General |
| 10/29/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $82.08 | General |
| 10/10/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $124.01 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2019 | CSL Behring | Idelvion (Biological) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: Hematology | ||||||
About Dr. Connie Piccone, MD
Dr. Connie Piccone, MD is a Pediatric Hematology-Oncology healthcare provider based in Urbana, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114956885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Connie Piccone, MD has received a total of $31,217 in payments from pharmaceutical and medical device companies, with $1,693 received in 2024. These payments were reported across 66 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,114).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Other Specialties Pediatrics, Pediatrics
- Location Urbana, IL
- Active Since 07/03/2006
- Last Updated 07/28/2025
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1114956885
Products in Payments
- ADAKVEO (Biological) $9,394
- OXBRYTA (Drug) $3,733
- PROMACTA (Drug) $143.67
- Afstyla (Biological) $62.95
- ADYNOVATE (Biological) $41.68
- Alphanate (Biological) $39.91
- Idelvion (Biological) $33.91
- NovoSeven RT (Drug) $30.96
- Kovaltry (Drug) $25.28
- DEFITELIO (Drug) $23.71
- SOLIRIS (Drug) $22.37
- Jivi (Drug) $20.80
- Defitelio (Drug) $19.99
- Novoeight (Drug) $17.49
- FERRIPROX (Drug) $15.97
- Eloctate (Drug) $15.56
- Blincyto (Biological) $14.96
- JADENU (Drug) $12.80
- XYNTHA (Biological) $12.77
- FEIBA (Biological) $11.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.